Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-NDESMO real world data and digital oncology

HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research.

25 more authors
35 affiliations
  1. 1Department of Medical Oncology, St Luke's Clinic, Thessaloniki, Greece.
  2. 2European University Cyprus, Engomi, Cyprus.
  3. 3Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Thessaloniki, Greece.
  4. 4Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  5. 5Regulatory/Legal Operations, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  6. 6Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece.
  7. 7Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  8. 8Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  9. 9First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  10. 10Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  11. 11Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  12. 12Division of Oncology, Department of Medicine, University Hospital of Patras, Medical School, Patras, Greece.
  13. 13Oncology Unit, Hippokration Hospital, Athens, Greece.
  14. 14Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  15. 15Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece.
  16. 16Department of Radiation Oncology, German Oncology Center, Limassol, Cyprus.
  17. 17Department of Medical Oncology, Medical School, Ioannina University Hospital, Ioannina, Greece.
  18. 18Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  19. 19Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece.
  20. 20Medical Oncology Unit, S. Andrew Hospital, Patras, Greece.
  21. 21Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  22. 22School of Health Sciences, University of Thessaly, Larissa, Greece.
  23. 23Radiation Oncology Department, University General Hospital of Larissa, Larissa, Greece.
  24. 24Second Radiation Oncology Clinic, Metropolitan Hospital, Piraeus, Greece.
  25. 25Department of Pathology, Ioannina University Hospital, Ioannina, Greece.
  26. 26Department of Pathology, University Hospital of Patras, Rion, Greece.
  27. 27Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece.
  28. 28Department of Pathology, Metaxas Cancer Hospital, Piraeus, Greece.
  29. 29Pathology Department, Metropolitan Hospital, Piraeus, Greece.
  30. 30Pathology Department, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  31. 31Department of Pathology, Henry Dunant Hospital, Athens, Greece.
  32. 32Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  33. 33First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  34. 34Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  35. 35Aristotle University of Thessaloniki, Thessaloniki, Greece.

Abstract

Background

Long-standing cooperative oncology groups are uniquely positioned to generate high-quality real-world data in diverse tumor types. The Hellenic Cooperative Oncology Group (HeCOG), a nonprofit scientific organization, has established a multi-institutional clinical database and biobank to support translational cancer research and precision oncology initiatives. Our aim was to describe the structure, governance and operation of HeCOG Biobank and patient registry.Materials and methods

The HeCOG clinical database is a centralized, web-based platform that supports interventional, observational, real-world and translational studies across affiliated institutions. Clinical data are linked to biospecimens stored in the HeCOG Biobank, preserved at the Laboratory of Molecular Oncology. Biospecimen collection, processing, storage, and data handling are governed by standardized operating procedures.Results

To date, the registry includes >54 000 patients with diverse tumors, enrolled retrospectively and prospectively. The associated biobank comprises >17 000 formalin-fixed paraffin-embedded tumor tissue samples and >6000 blood-derived specimens. The largest tissue collections are from breast, colorectal, and lung cancer. Molecular and histopathological biomarker data are also available for several thousand patients within the registry. Biospecimens are uniquely coded and linked to pseudonymized longitudinal clinical, histopathological, and molecular data. Ongoing expansion includes digital pathology and radiological imaging datasets, further enhancing the translational potential of the resource.Conclusions

The HeCOG Biobank and the accompanying clinical database have evolved into a valuable resource for translational cancer research in Greece. Through the ongoing integration of digital pathology, imaging data, and artificial intelligence-based approaches it provides a strong basis for precision oncology and collaborative national and international research.

Related

  1. Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on “Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462”
    Shinya Kajiura, Hironaga Satake, Ryuji Hayashi +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Artificial intelligence for women’s reproductive health: A scoping review of global diagnostic trends, methodological gaps, and a translational research agenda for low-resource settings
    Mohammad Mehedi Hasan Munna, Toriqul Islam, Omar Faruk +6
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyPhysiologyPLOS
  3. Elective cholecystectomy benchmarks: nationwide registry study
    BJS openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Incidence, Prevalence and Diagnostic Delay in Pyoderma Gangrenosum: A Finnish Nationwide Registry-based Study.
    Suvi-Päivikk Sinikumpu, Jari Jokelainen, Laura Huilaja
    Acta dermato-venereologicaPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  5. Sepsis-related hospitalisation risk in preterm-born and term-born children and adolescents: a nationwide registry study
    Jonas Valand, Sara Marie Nilsen, Andreas Asheim +5
    eClinicalMedicinePeer-reviewedCC BY 4.0General medicineCrossref
BibTeX
@article{fountzilas2026hecog,
  title = {{HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research.}},
  author = {E Fountzilas and K Papadopoulou and G-A Koliou and T Papapavlou and D Pectasides and C Christodoulou and E Samantas and D Bafaloukos and G Aravantinos and P A Kosmidis and H P Kalofonos and J Sgouros and P Papakostas and E Razis and T Economopoulos and N Zamboglou and A Koutras and G Pentheroudakis and F Zagouri and H Linardou and A Christopoulou and D Papamichael and P Skarlos and A Batistatou and A Goussia and H P Kourea and S Pervana and O Tzaida and K Petraki and K Pavlakis and P Arapantoni-Dadioti and T Koletsa and V Kotoula and N Pavlidis and H Gogas and A Psyrri and G Fountzilas},
  journal = {ESMO real world data and digital oncology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.esmorw.2026.100788},
  url = {https://europepmc.org/article/MED/42903694},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research.
AU  - E Fountzilas
AU  - K Papadopoulou
AU  - G-A Koliou
AU  - T Papapavlou
AU  - D Pectasides
AU  - C Christodoulou
AU  - E Samantas
AU  - D Bafaloukos
AU  - G Aravantinos
AU  - P A Kosmidis
AU  - H P Kalofonos
AU  - J Sgouros
AU  - P Papakostas
AU  - E Razis
AU  - T Economopoulos
AU  - N Zamboglou
AU  - A Koutras
AU  - G Pentheroudakis
AU  - F Zagouri
AU  - H Linardou
AU  - A Christopoulou
AU  - D Papamichael
AU  - P Skarlos
AU  - A Batistatou
AU  - A Goussia
AU  - H P Kourea
AU  - S Pervana
AU  - O Tzaida
AU  - K Petraki
AU  - K Pavlakis
AU  - P Arapantoni-Dadioti
AU  - T Koletsa
AU  - V Kotoula
AU  - N Pavlidis
AU  - H Gogas
AU  - A Psyrri
AU  - G Fountzilas
PY  - 2026
DA  - 2026/10/12
JO  - ESMO real world data and digital oncology
DO  - 10.1016/j.esmorw.2026.100788
UR  - https://europepmc.org/article/MED/42903694
AB  - Background  Long-standing cooperative oncology groups are uniquely positioned to generate high-quality real-world data in diverse tumor types. The Hellenic Cooperative Oncology Group (HeCOG), a nonprofit scientific organization, has established a multi-institutional clinical database and biobank to support translational cancer research and precision oncology initiatives. Our aim was to describe the structure, governance and operation of HeCOG Biobank and patient registry.Materials and methods  The HeCOG clinical database is a centralized, web-based platform that supports interventional, observational, real-world and translational studies across affiliated institutions. Clinical data are linked to biospecimens stored in the HeCOG Biobank, preserved at the Laboratory of Molecular Oncology. Biospecimen collection, processing, storage, and data handling are governed by standardized operating procedures.Results  To date, the registry includes >54 000 patients with diverse tumors, enrolled retrospectively and prospectively. The associated biobank comprises >17 000 formalin-fixed paraffin-embedded tumor tissue samples and >6000 blood-derived specimens. The largest tissue collections are from breast, colorectal, and lung cancer. Molecular and histopathological biomarker data are also available for several thousand patients within the registry. Biospecimens are uniquely coded and linked to pseudonymized longitudinal clinical, histopathological, and molecular data. Ongoing expansion includes digital pathology and radiological imaging datasets, further enhancing the translational potential of the resource.Conclusions  The HeCOG Biobank and the accompanying clinical database have evolved into a valuable resource for translational cancer research in Greece. Through the ongoing integration of digital pathology, imaging data, and artificial intelligence-based approaches it provides a strong basis for precision oncology and collaborative national and international research.
SN  - 2949-8201
ER  -